GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $31,061,000 | +106.2% | 457,993 | +76.9% | 0.16% | +107.8% |
| Q2 2019 | $15,062,000 | -7.1% | 258,940 | +11.9% | 0.08% | -10.5% |
| Q1 2019 | $16,213,000 | +8.5% | 231,460 | -0.2% | 0.09% | -8.5% |
| Q4 2018 | $14,938,000 | -14.3% | 231,925 | -6.6% | 0.09% | +11.9% |
| Q3 2018 | $17,437,000 | +34.8% | 248,327 | -3.3% | 0.08% | +20.0% |
| Q2 2018 | $12,937,000 | +38.1% | 256,698 | -14.3% | 0.07% | +37.3% |
| Q1 2018 | $9,370,000 | -16.3% | 299,459 | -9.2% | 0.05% | -17.7% |
| Q4 2017 | $11,190,000 | -0.3% | 329,625 | -6.0% | 0.06% | -3.1% |
| Q3 2017 | $11,220,000 | -9.2% | 350,847 | -7.5% | 0.06% | -14.7% |
| Q2 2017 | $12,351,000 | +22.4% | 379,473 | +18.4% | 0.08% | +19.0% |
| Q1 2017 | $10,094,000 | +7.9% | 320,553 | +0.7% | 0.06% | +1.6% |
| Q4 2016 | $9,358,000 | +11.2% | 318,431 | +9.4% | 0.06% | +8.8% |
| Q3 2016 | $8,417,000 | – | 291,066 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
| Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
| Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
| Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
| Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
| Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
| CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
| Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |